Event Group
Event Groups are part of the Adverse Events Module within the Results Section. They provide a way to organize and summarize adverse event data by grouping related events together.
Each Event Group typically represents a category or class of adverse events and includes statistical information such as the number of participants affected and at risk for different event types: deaths, serious events, and other events.
Event Group path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Group
Event Group
Ignite Creation Date:
2025-12-24 @ 5:01 PM
Ignite Modification Date:
2025-12-25 @ 2:42 PM
NCT ID:
NCT03279250
Group ID:
EG000
Title:
Arm A (LHRHa, Apalutamide)
Description:
Participants receive gonadotropin-releasing hormone analog (leuprolide, goserelin, or triptorelin as determined by treating physician) IM once every 3 months and apalutamide PO QD. Treatment repeats every 28 days for up to 6 cycles in the absence of disease progression or unacceptable toxicity. Beginning no less than 48 hours after completion of therapy, participants undergo radical prostatectomy.
Apalutamide: Given PO
Gonadotropin-releasing Hormone Analog: Given IM
Radical Prostatectomy: Undergo radical prostatectomy
Deaths Number Affected:
1
Deaths Number At Risk:
None
Serious Number Affected:
1
Serious Number At Risk:
34
Other Number Affected:
34
Other Number At Risk:
34
Study:
NCT03279250
Results Section:
NCT03279250
Adverse Events Module:
NCT03279250